Medicare Enrolled

Dr. Shametria Tann

Nurse Practitioner - Family · Missouri City, TX
Low-engagement
3003 TEXAS PKWY UNIT B, Missouri City, TX 77489
3463748402
In practice since 2020 (5 years)
NPI: 1124615612 verify on NPPES ↗
Moderate
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Tann from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Tann? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Tann

Dr. Shametria Tann is a nurse practitioner - family in Missouri City, TX, with 5 years in practice.

Between the years covered by Open Payments, Dr. Tann received a total of $1,635 from 31 pharmaceutical and/or device companies across 68 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in nurse practitioner - family. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Tann is Moderate — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 5 years in practice$ $1,635 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$1,635
Total received (2023-2024)
Avg $818/year across 2 years
Top 19% in TX for nurse practitioner - family
31
Companies
68
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$1,411 (86.3%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$224 (13.7%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,549
2023
$86

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$211
PFIZER INC.
$155
Merck Sharp & Dohme LLC
$145
Janssen Biotech, Inc.
$136
E.R. Squibb & Sons, L.L.C.
$124
Incyte Corporation
$88
Rigel Pharmaceuticals, Inc.
$77
Takeda Pharmaceuticals U.S.A., Inc.
$61
GlaxoSmithKline, LLC.
$57
TerSera Therapeutics LLC
$54
Astellas Pharma US Inc
$50
Regeneron Healthcare Solutions, Inc.
$49
SOBI, INC
$48
Lilly USA, LLC
$41
Celgene Corporation
$31
Adaptive Biotechnologies Corporation
$26
EMD Serono, Inc.
$26
Deciphera Pharmaceuticals Inc.
$25
Daiichi Sankyo Inc.
$22
ABBVIE INC.
$21
Bayer Healthcare Pharmaceuticals Inc.
$21
Mirati Therapeutics, Inc.
$20
SERVIER PHARMACEUTICALS LLC
$20
ADC Therapeutics America, Inc.
$18
Novartis Pharmaceuticals Corporation
$18
Aveo Pharmaceuticals, Inc.
$18
Ipsen Biopharmaceuticals, Inc
$17
Karyopharm Therapeutics Inc.
$17
SCPHARMACEUTICALS INC.
$15
Tactile Systems Technology Inc
$14
Janssen Pharmaceuticals, Inc
$12
Top 3 companies account for 31.2% of total payments
Associated products mentioned in payments ›
ALUNBRIG · ELAHERE · ERLEADA · Enhertu · FARXIGA · FOTIVDA · FUROSCIX · Flexitouch Plus · IBRANCE · IMFINZI · INLYTA · JAKAFI · KEYTRUDA · KRAZATI · LIBTAYO · MEKINIST · MONJUVI · OJJAARA · Onivyde · PADCEV · Padcev · QINLOCK · REBLOZYL · RYBREVANT · Rezlidhia · SYNAGIS · Stivarga · TAGRISSO · TECVAYLI · VERQUVO · VERZENIO · VONJO · VYNDAMAX · Voranigo · Vyloy · XPOVIO · Zoladex · clonoSEQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (86%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a nurse practitioner - family in Missouri City?
Compare nurse practitioner - familys in the Missouri City area by procedure volume, costs, and industry payment transparency.
Browse nurse practitioner - familys nearby

Geographic Context

Nurse Practitioner - Familys within 10 mi
3,060
Per 100K population
355.9
County median income
$113,409
Nearest hospital
ST LUKE'S SUGAR LAND HOSPITAL
5.7 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data— No dataN/A
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of Moderate. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Tann is a nurse practitioner - family, and high industry engagement (low-engagement, top 19%).

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Does Dr. Tann receive payments from pharmaceutical companies?
Yes. Dr. Tann received a total of $1,635 from 31 companies across 68 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently Moderate for Dr. Tann) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →